{"name":"Venture Investors","permalink":"venture-investors","crunchbase_url":"http://www.crunchbase.com/financial-organization/venture-investors","homepage_url":"http://www.ventureinvestors.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"608-441-2700","description":"","email_address":"","number_of_employees":null,"founded_year":1982,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Oct 08 10:22:57 UTC 2009","updated_at":"Thu Oct 08 11:14:47 UTC 2009","overview":"<p>Venture Investors is a premier provider of seed and early stage venture capital in the Midwest. They have a proven track record of working with world-class healthcare and technology companies throughout the region.</p>","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"University Research Park","address2":"505 S. Rosa Road, Suite 201","zip_code":"53719","city":"Madison","state_code":"WI","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.inviragen.com/press/Inviragen_SingVax%20Press%20Release100609.pdf","source_description":"Inviragen Completes $15 million Series A Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":6,"company":{"name":"Inviragen","permalink":"inviragen","image":{"available_sizes":[[[150,82],"assets/images/resized/0006/2054/62054v1-max-150x150.jpg"],[[167,92],"assets/images/resized/0006/2054/62054v1-max-250x250.jpg"],[[167,92],"assets/images/resized/0006/2054/62054v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.jsonline.com/business/29526324.html","source_description":"New firm aims to microwave cancer","raised_amount":4500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":8,"company":{"name":"NeuWave Medical ","permalink":"neuwave-medical","image":{"available_sizes":[[[150,33],"assets/images/resized/0007/0273/70273v1-max-150x150.jpg"],[[250,55],"assets/images/resized/0007/0273/70273v1-max-250x250.jpg"],[[326,72],"assets/images/resized/0007/0273/70273v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.ventureinvestors.com/archives/205","source_description":"SILATRONIXâ€™S BETTER BATTERY PLAN DRAWS ON MADISON CHEMISTS","raised_amount":500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":13,"company":{"name":"Silatronix","permalink":"silatronix","image":{"available_sizes":[[[150,44],"assets/images/resized/0007/2693/72693v1-max-150x150.jpg"],[[250,74],"assets/images/resized/0007/2693/72693v1-max-250x250.jpg"],[[329,98],"assets/images/resized/0007/2693/72693v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1600000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":1,"company":{"name":"Chromatin","permalink":"chromatin","image":{"available_sizes":[[[150,34],"assets/images/resized/0008/5331/85331v1-max-150x150.jpg"],[[247,56],"assets/images/resized/0008/5331/85331v1-max-250x250.jpg"],[[247,56],"assets/images/resized/0008/5331/85331v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2011/03/07/daily34-Euthymics-Bioscience-bumps-Series-A-to-28M.html","source_description":"Euthymics Bioscience bumps Series A to $28M","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":9,"company":{"name":"Euthymics Bioscience","permalink":"euthymics-bioscience","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/4756/94756v1-max-150x150.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-250x250.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.akebia.com/news/Akebia_Srs_B_Financing.pdf","source_description":"AKEBIA COMPLETES $22M SERIES B FINANCING","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":26,"company":{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.mithridion.com/pdf/news_releases/2011/Mithridion_News_Release_110111_Final.pdf","source_description":"Mithridion Inc Announces New Funding and Outlines Strategy for Central Nervous System Drug Development","raised_amount":1250000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":11,"company":{"name":"Mithridion","permalink":"mithridion","image":{"available_sizes":[[[150,69],"assets/images/resized/0013/5650/135650v1-max-150x150.png"],[[202,94],"assets/images/resized/0013/5650/135650v1-max-250x250.png"],[[202,94],"assets/images/resized/0013/5650/135650v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/01/akebia-therapeutics-raises-4-1m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Akebia Therapeutics Raises $4.1M in Series B Financing","raised_amount":4100000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":9,"company":{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/07/juventas-therapeutics-closes-22-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Juventas Therapeutics Closes $22.2M Series B Financing","raised_amount":22200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":16,"company":{"name":"Juventas Therapeutics","permalink":"juventas-therapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0013/2328/132328v1-max-150x150.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-250x250.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/08/aerpio-therapeutics-closes-27m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Aerpio Therapeutics Closes $27M Series A Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":30,"company":{"name":"Aerpio Therapeutics","permalink":"aerpio-therapeutics","image":{"available_sizes":[[[97,65],"assets/images/resized/0020/9041/209041v1-max-150x150.png"],[[97,65],"assets/images/resized/0020/9041/209041v1-max-250x250.png"],[[97,65],"assets/images/resized/0020/9041/209041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/09/neuwave-medical-raises-14m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"NeuWave Medical Raises $14M in Series B Financing","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":5,"company":{"name":"NeuWave Medical ","permalink":"neuwave-medical","image":{"available_sizes":[[[150,33],"assets/images/resized/0007/0273/70273v1-max-150x150.jpg"],[[250,55],"assets/images/resized/0007/0273/70273v1-max-250x250.jpg"],[[326,72],"assets/images/resized/0007/0273/70273v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/neurovance-closes-7m-series-a1-113200571.html","source_description":"Neurovance Closes $7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":18,"company":{"name":"Neurovance","permalink":"neurovance","image":null}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}